Harvard Bioscience Inc (NASDAQ:HBIO)
| 3.09 Delayed Data As of Mar 24 |  -0.09 / -2.83%Today’s Change | 1.98 Today|||52-Week Range 6.49 | +11.55% Year-to-Date |
Latest HBIO News | Press Releases
No recent news for Harvard Bioscience Inc.
Today’s Trading
| Previous close | 3.18 |
| Today’s open | 3.10 |
| Day’s range | 3.02 - 3.14 |
| Volume | 1,127 |
| Average volume (3 months) | 107,196 |
| Market cap | $118.1M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -3,136.62% |
| Earnings growth (this year) | +108.33% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | -4.68% |
| P/E ratio | NM |
| Price/Sales | 1.01 |
| Price/Book | 1.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Standard BioTools In... | -0.05 | -2.36% |
| LABStandard BioTools In... | -0.05 | -2.36% |
| BFNHBioForce Nanoscience... | 0.00 | 0.00% |
| --Chromocure Inc | 0.00 | 0.00% |
Data as of 3:59pm ET, 03/24/2023
Financials
| Next reporting date | May 3, 2023 |
| EPS forecast (this quarter) | $0.05 |
| Annual revenue (last year) | $113.3M |
| Annual profit (last year) | -$9.5M |
| Net profit margin | -8.40% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Holliston, Massachusetts |
Forecasts
